Travis Young, Calibr VP of biologics (Scripps)

Four years in the mak­ing, Ab­b­Vie and Cal­i­br pro­vide first look in­to ‘switch­able’ CAR-T pro­gram

In 2018, Ab­b­Vie and Cal­i­br — a branch of Scripps Re­search In­sti­tute — an­nounced a part­ner­ship for a next-gen CAR-T pro­gram, then still in its pre­clin­i­cal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.